Compare WT & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WT | PBH |
|---|---|---|
| Founded | 1985 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2011 | 2004 |
| Metric | WT | PBH |
|---|---|---|
| Price | $20.03 | $49.88 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $17.67 | ★ $75.33 |
| AVG Volume (30 Days) | ★ 3.1M | 642.2K |
| Earning Date | 05-01-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | ★ 127.27 | N/A |
| EPS | N/A | ★ 3.91 |
| Revenue | $493,753,000.00 | ★ $975,777,000.00 |
| Revenue This Year | $35.04 | N/A |
| Revenue Next Year | $8.68 | $4.31 |
| P/E Ratio | ★ N/A | $12.95 |
| Revenue Growth | 15.43 | ★ 36.77 |
| 52 Week Low | $10.69 | $42.62 |
| 52 Week High | $20.37 | $77.45 |
| Indicator | WT | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 62.64 | 54.69 |
| Support Level | $15.86 | $44.86 |
| Resistance Level | N/A | $63.56 |
| Average True Range (ATR) | 0.74 | 1.52 |
| MACD | 0.22 | 0.25 |
| Stochastic Oscillator | 89.28 | 63.48 |
WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.